Review Article
Plant-Derived Products for Treatment of Vascular Intima Hyperplasia Selectively Inhibit Vascular Smooth Muscle Cell Functions
Table 6
The selected potential targets of the compounds.
| ā | Idarubicin | Halofuginone | Piperine | -elemene | Curcumin | Coptisine | Seq | Predicted target names (most related top 15) |
| 1 | MAPT | BCHE | MAOA | MAPT | MAPT | CHRM4 | 2 | MBNL1 | ACHE | MAOB | TDP1 | TLR9 | CHRM1 | 3 | MBNL2 | MAPK8 | SIGMAR1 | CXCR3 | TDP1 | CHRM2 | 4 | MBNL3 | MAPK9 | MBNL1 | SLC6A2 | Unknown | CHRM5 | 5 | MMP2 | MAPK10 | MBNL2 | SLC6A3 | MBNL1 | CHRM3 | 6 | MMP9 | MAPK11 | MBNL3 | LDLR | MBNL2 | BCHE | 7 | APP | MAPK14 | MAPT | VLDLR | MBNL3 | ADRA2A | 8 | SNCA | HTR1A | DRD2 | LRP8 | GLO1 | CYP2D6 | 9 | APLP2 | HTR1B | DRD3 | HSD11B1 | AKT1 | ADRA2B | 10 | SNCG | MAPT | HDAC3 | BACE1 | AKT2 | ADRA2C | 11 | SNCB | HTR2A | HDAC1 | HSD11B1L | AKT3 | ACHE | 12 | TDP1 | DRD2 | HDAC2 | BACE2 | HSD17B3 | HTR2A | 13 | EGFR | DRD1 | DYRK1A | HTR1A | HSD17B12 | HTR2C | 14 | ERBB2 | OPRM1 | HDAC6 | HTR1D | CRYZ | HTR2B | 15 | ERBB3 | OPRD1 | CTSL1 | HTR1B | APP | SIGMAR1 |
|
|